neuroblastoma
Showing 1 - 25 of 393
Neuroblastoma, Ganglioneuroblastoma Trial in Moscow (monoclonal antibodies GD2)
Recruiting
- Neuroblastoma
- Ganglioneuroblastoma
- monoclonal antibodies GD2
-
Moscow, Russian FederationResearch Institute of Pediatric Hematology, Oncology and Immunol
Oct 4, 2023
Neuroblastoma, High-risk Neuroblastoma, Metastatic Neuroblastoma Trial in United States (OPT-821 (QS-21), oral ß-glucan)
Recruiting
- Neuroblastoma
- +2 more
- OPT-821 (QS-21)
- oral β-glucan
-
Basking Ridge, New Jersey
- +6 more
Sep 21, 2023
Neuroblastoma Trial in Guangzhou (Naxitamab monotherapy, GM-CSF, Irinotecan)
Recruiting
- Neuroblastoma
- Naxitamab monotherapy
- +6 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Aug 31, 2023
Glioma, Childhood Brainstem, Neuroblastoma Trial in San Francisco, Boston (External beam radiotherapy,
Not yet recruiting
- Glioma, Childhood Brainstem
- Neuroblastoma
- External beam radiotherapy
- 131I-Metaiodobenzylguanidine (MIBG)
-
San Francisco, California
- +1 more
Aug 17, 2023
Neuroblastoma Trial (GD2 CAR T cells)
Not yet recruiting
- Neuroblastoma
- GD2 CAR T cells
- (no location specified)
Aug 5, 2023
Neuroblastoma Patients
Not yet recruiting
- Neuroblastoma
-
San Francisco, CaliforniaPower Life Sciences
Jun 15, 2023
Brain Tumor, Kidney Tumor, Neuroblastoma Trial in Villejuif (Skin biopsy, Fresh tumor sample, Blood sample)
Recruiting
- Brain Tumor
- +3 more
- Skin biopsy
- +4 more
-
Villejuif, FranceGustave Roussy
May 26, 2023
Neuroblastoma Trial in Copenhagen (18FmFBG imaging on the Large Field of View PET/CT (Total body PET/CT))
Recruiting
- Neuroblastoma
- 18FmFBG imaging on the Large Field of View PET/CT (Total body PET/CT)
-
Copenhagen, DenmarkRigshospitalet, Copenhagen University Hospital
Apr 11, 2023
Neuroblastoma Trial in Esplugues De Llobregat (Immersive virtual reality imaging, Gold standard imaging)
Recruiting
- Neuroblastoma
- Immersive virtual reality imaging
- Gold standard imaging
-
Esplugues De Llobregat, Barcelona, SpainHospital Sant Joan de Déu
Mar 23, 2023
Neuroblastoma Trial in Moscow, Saint Petersburg (BCD-245)
Recruiting
- Neuroblastoma
- BCD-245
-
Moscow, Russian Federation
- +2 more
Mar 13, 2023
Neuroblastoma Trial (horse therapy)
Not yet recruiting
- Neuroblastoma
- horse therapy
- (no location specified)
Feb 22, 2023
Neuroblastoma, Cancer Trial in Philadelphia (procedure, genetic, other, behavioral, drug)
Terminated
- Neuroblastoma
- Cancer
- Biopsy
- +12 more
-
Philadelphia, PennsylvaniaThe Children's Hospital of Philadelphia
Jan 31, 2023
Ganglioneuroblastoma, Ganglioneuroma, Metastatic Neuroblastoma Trial in Rochester (Computed Tomography, Gallium Ga 68-DOTATATE,
Recruiting
- Ganglioneuroblastoma
- +2 more
- Computed Tomography
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 30, 2023
Sarcoma, Osteosarcoma, Neuroblastoma Trial run by the NCI (Anti-GD2-CAR engineered T cells, AP1903, Cyclophosphamide)
Completed
- Sarcoma
- +3 more
- Anti-GD2-CAR engineered T cells
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 31, 2023
Neuroblastoma Trial in Canada, United States (Sorafenib, Cyclophosphamide, Topotecan)
Active, not recruiting
- Neuroblastoma
- Sorafenib
- +2 more
-
Los Angeles, California
- +11 more
Jan 30, 2023
Colorectal Carcinoma, Endometrial Carcinoma, Melanoma Trial in United States (Tegavivint)
Recruiting
- Colorectal Carcinoma
- +21 more
- Dual X-ray Absorptiometry
- +2 more
-
Birmingham, Alabama
- +18 more
Jan 30, 2023
Neuroblastoma Trial in United States (131I-MIBG, Dinutuximab, Vorinostat)
Recruiting
- Neuroblastoma
- 131I-MIBG
- +4 more
-
Los Angeles, California
- +11 more
Jan 30, 2023
Endocrine Neoplasms
Recruiting
- Endocrine Tumors
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023